2019
DOI: 10.1111/bcp.13862
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic herb‐drug interaction between ginger and crizotinib

Abstract: The use of complementary and alternative medicine at least once during or after cancer treatment has increased over the past years from an estimated 25% in the 1970s and 1980s to more than 32% in the 1990s and to 49% after 2000. The risk of herb‐drug interaction is therefore increasingly recognized as a public health problem. To the best of our knowledge, we report here the first case of interaction between ginger and anticancer drug, with serious consequences for the patient. There is an urgent need regarding… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
28
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(30 citation statements)
references
References 17 publications
0
28
0
Order By: Relevance
“…Can delay or reduce drug absorption; 1 h time-lag between application [69] Minerals, vitamins, drugs obstruction risk with drugs that inhibit peristaltic movements Opioids Garlic Inhibition of CYP2E1 [70], but not 2D6 and 3A4 [70,71]; induces pGP [72] Cyclosporine, tacrolimus Elevated bleeding risk due to platelet inhibition suspected [53,73]; contradicting clinical data [73,74] Monitor patients on anticoagulants when starting/ending garlic preparations; caution with antiplatelet drugs (NSAIDs, especially ASA) [75][76][77]; cases of interactions with dabigatran (pGP) [78], phenprocoumon (CYP2C9) [79], and crizotinib (CYP3A4, 2C9; pGP) [80]; no effect in a clinical study with warfarin (CYP2C9) [81]; elevated tacrolimus AUC in rats [82] CYP2C9, 3A4 and pGP substrates with narrow therapeutic window, such as cyclosporine, tacrolimus Inhibits platelet aggregation in vitro [83] Caution with anticoagulant and platelet-aggregation inhibiting drugs (NSAIDs) Inhibits UDP1A6 in vitro [86]; CYP3A4 and 2C9 inhibition suspected, but no relevant influence in small clinical studies [87][88][89][90][91]; case report of warfarin interaction, probably due to CYP2C9 inhibition [92] Caution with CYP3A4 and 2C9 substrates with small therapeutic windows (such as cyclosporine)…”
Section: Flaxseedmentioning
confidence: 99%
“…Can delay or reduce drug absorption; 1 h time-lag between application [69] Minerals, vitamins, drugs obstruction risk with drugs that inhibit peristaltic movements Opioids Garlic Inhibition of CYP2E1 [70], but not 2D6 and 3A4 [70,71]; induces pGP [72] Cyclosporine, tacrolimus Elevated bleeding risk due to platelet inhibition suspected [53,73]; contradicting clinical data [73,74] Monitor patients on anticoagulants when starting/ending garlic preparations; caution with antiplatelet drugs (NSAIDs, especially ASA) [75][76][77]; cases of interactions with dabigatran (pGP) [78], phenprocoumon (CYP2C9) [79], and crizotinib (CYP3A4, 2C9; pGP) [80]; no effect in a clinical study with warfarin (CYP2C9) [81]; elevated tacrolimus AUC in rats [82] CYP2C9, 3A4 and pGP substrates with narrow therapeutic window, such as cyclosporine, tacrolimus Inhibits platelet aggregation in vitro [83] Caution with anticoagulant and platelet-aggregation inhibiting drugs (NSAIDs) Inhibits UDP1A6 in vitro [86]; CYP3A4 and 2C9 inhibition suspected, but no relevant influence in small clinical studies [87][88][89][90][91]; case report of warfarin interaction, probably due to CYP2C9 inhibition [92] Caution with CYP3A4 and 2C9 substrates with small therapeutic windows (such as cyclosporine)…”
Section: Flaxseedmentioning
confidence: 99%
“…Derivatives of ginger such as gingerol, shogaols, galanolactone, and diterpenoid were also established to reduce nausea and vomiting [92]. Others revealed that the reports of management of nausea and vomiting in cancer patients are also available in the literature [93].…”
Section: Antiemeticmentioning
confidence: 99%
“…Compelling evidence has shown that some herbal medicines cause serious organ damage, which constrains their clinical application. 25-27…”
Section: Introductionmentioning
confidence: 99%
“…Compelling evidence has shown that some herbal medicines cause serious organ damage, which constrains their clinical application. [25][26][27] The anti-fibrotic and anti-hepatocarcinoma properties may rest with either the suppression of cell proliferation or the induction of cell death, which would be reflected by a change in cell viability. The ultimate objective of this study was to investigate the cell death patterns induced by TFPCE and Th-A.…”
Section: Introductionmentioning
confidence: 99%